Safety of Satralizumab Based on Pooled Data from Phase 3 Studies in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) (1281)
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
10.1212/wnl.94.15_supplement.1281